BESHAR LUKE M 4
4 · Protara Therapeutics, Inc. · Filed Mar 14, 2022
Insider Transaction Report
Form 4
BESHAR LUKE M
Director
Transactions
- Purchase
Common Stock
2022-03-10$4.46/sh+10,000$44,555→ 178,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.28 to $4.50, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.